Trial intelligence / Profile preview

Effect of caffeine on neurorehabilitation after stroke

IRCT2017021832625N1Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of caffeine in stroke, sponsored by Shiraz University of Medical Sciences. Started Apr 2017; status: completed.

02

Drugs

caffeine
03

Conditions

stroke

Beyond the preview

Go deeper on IRCT2017021832625N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017021832625N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call